Cardiovascular

BNP Test: Key Diagnostic Step for Heart Failure (PEP Study)

September 3, 2007 ⋅ Post a comment
John Cleland
John Cleland
Maarten Simoons
Maarten Simoons

REFERENCE: Hot Line 1 Sunday 11:00 2 Sept, European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria
JOHN CLELAND, University of Hull
COMMENT: MAARTEN SIMOONS, Erasmus University, Rotterdam
A new blood test using brain natriuretic peptide or BNP could become the primary step for diagnosing heart failure. This is according to the latest results from the Perindopril for Elderly People with Chronic Heart Failure or PEP-CHF study that measured levels of BNP in heart failure patients who had previously had echocardiograms. It found that many patients had been misdiagnosed. These results suggest that the BNP test should go before the echocardiogram for diagnosing patients with heart failure. Sarah Maxwell discussed the findings with study author John Cleland at the ESC meeting in Vienna.
Maarten Simoons of Erasmus University in Rotterdam commented on the PEP study findings.

Similar Interviews

  • Rosuvastatin: No Significant Benefit for Older Patients with Systolic Heart Failure: CORONA Study Results

    • Ake Hjalmarson Gordon Tomaselli REFERENCE: Late Breaking Clinical Trials, Session 2, American Heart Association Scientific Sessions,

  • Human Growth Hormone: Responses in Severe Heart Failure

    • Catherine Demers Recombinent human growth hormone has achieved clinical responses when used for treating heart failure. Catherine Demers of McMaster University

  • Levosimendan Improves Heart Failure Progression

    • Milton Packer In the REVIVE trial the inotropic agent levosimendan has improved short-term outcome in acutely decompensated heart failure. Milton Packer

    1. [...] of BNP in heart failure patients who had previously had echocardiograms. …Original post by admin delivered by Medtrials and [...]

      Posted by   Audio Journal of Cardiovascular Medicine: BNP Test: Key Diagnostic … by medTRIALS.info | September 4, 2007, 2:09 am

    Post a comment

    LDL-How Low?»
    Terje Pedersen, Ulleval University, Oslo
    Lowering LDL Cholesterol intensively as a means of treating aortic stenosis was found to have no benefit in the SEAS (Simvastatin and Ezetimibe In Aortic Stenosis) study reported by Terje Pederson at a Hot Line session of the E.S.C. Congress. But the potential gains from such lowering in other clinical situations could be considerable, according to Eugene Braunwald who chaired the session. In Munich they talked with Peter Goodwin.
    LSHTM Audio News»
    Bayard Roberts, Siân Clarke, Sandy Cairncross, Claire Bertschinger and Virginia Berridge
    Derek Thorne and Peter Goodwin talk with Bayard Roberts, Siân Clarke, Sandy Cairncross, Claire Bertschinger and Virginia Berridge of The London School of Hygiene and Tropical Medicine about:
    - depression and post traumatic stress disorder in war-torn northern Uganda and the lessons to be drawn from a research project there; - the unexpected additional value of using malaria drugs at regular intervals among school children in Kenya; - the key role of sanitation in preventing infant deaths all over the world and what is being done to improve it; - the life and work of the nurse who inspired Band Aid and Live Aid, as she receives an honorary doctorate; - the \"marketing\" of health to the British public, as illustrated by the way attitudes to smoking have changed over the years.
    Subscribe to Audio Medica Podcast